10-Q: Hercules Capital Reports Q1 2025 Results: Investment Portfolio Reaches $3.9 Billion
Quarterly Report
Hercules Capital's Q1 2025 results show a robust investment portfolio valued at $3.9 billion, despite a net decrease in net assets resulting from operations.
Summary
- Hercules Capital's investment portfolio reached $3.9 billion in Q1 2025.
- The company reported a net decrease in net assets resulting from operations of $50.3 million.
- Net investment income was $77.5 million, or $0.45 per share.
- The company issued $287.5 million in convertible notes due in 2028.
- The company declared a cash distribution of $0.40 per share and a supplemental distribution of $0.07 per share.
- The company sold 2.0 million shares of common stock for net proceeds of $39.4 million.
- The company's weighted average cost of debt was 4.9%.
Sentiment
Score: 6
Explanation: The document presents a mixed sentiment. While the investment portfolio continues to grow, there are concerns about net losses and unrealized depreciation. The company's ability to navigate the current economic environment and generate sustainable returns will be key.
Positives
- The investment portfolio continues to grow, reaching $3.9 billion.
- The company successfully issued $287.5 million in convertible notes.
- The company continues to generate investment income and distribute dividends to shareholders.
Negatives
- The company experienced a net decrease in net assets resulting from operations.
- Net realized losses were recorded for the period.
- There was a net change in unrealized depreciation on investments.
Risks
- Changes in interest rates could negatively impact net investment income.
- Macroeconomic market developments could negatively impact the company and its portfolio companies.
- The company's financial results could be negatively affected if a significant portfolio investment fails to perform as expected.
Future Outlook
The company intends to continue to operate in order to generate cash flows from operations, including income earned from investments in our portfolio companies. Our primary use of funds will be investments in portfolio companies and cash distributions to holders of our common stock.
Industry Context
Hercules Capital operates in the specialty finance sector, focusing on venture capital-backed technology and life sciences companies. The company's performance is influenced by broader market trends, interest rate fluctuations, and the success of its portfolio companies. The company's focus on high-growth sectors positions it to benefit from innovation and expansion in these areas, but also exposes it to risks associated with early-stage companies and market volatility.
Comparison to Industry Standards
- Hercules Capital is a business development company (BDC), and its performance can be compared to other BDCs such as Ares Capital Corporation (ARCC), Main Street Capital Corporation (MAIN), and Prospect Capital Corporation (PSEC).
- These companies also invest in debt and equity of private companies, but their investment strategies, portfolio compositions, and risk profiles may differ.
- Hercules Capital's focus on technology and life sciences distinguishes it from some other BDCs that may have broader investment mandates.
- The company's weighted average yield on debt investments and its asset coverage ratio are key metrics to compare against industry averages and benchmarks.
- The company's performance can also be compared to venture capital and private equity funds that invest in similar sectors, although BDCs have different regulatory and tax structures.
Related Party Transactions
- The company has a shared services agreement with the Adviser Subsidiary, through which the Adviser Subsidiary has access to the Company's human capital resources and other resources and infrastructure.
- The company may from time-to-time make investments alongside the Adviser Funds or assign a portion of investments to the Adviser Funds in accordance with the Company's allocation policy.
Stakeholder Impact
- Stockholders will receive a cash distribution of $0.40 per share and a supplemental distribution of $0.07 per share.
- The company's performance will impact the value of stockholders' investments.
- The company's ability to generate sustainable returns will be key for long-term stockholder value.
Next Steps
- The company will continue to monitor macroeconomic market developments and their impact on its business.
- The company will continue to evaluate its overall liquidity position and take proactive steps to maintain the appropriate liquidity position based upon the current circumstances.
- The company intends to timely distribute to its stockholders substantially all of its annual taxable income for each year.
Key Dates
| Date | Description |
|---|---|
| 2003-12 | Hercules Capital, Inc. was incorporated. |
| 2006-01-01 | Hercules Capital elected to be treated as a Regulated Investment Company (RIC). |
| 2018-06-28 | The 2018 Equity Incentive Plan and 2018 Non-Employee Director Plan were approved by stockholders. |
| 2018-09-24 | The Company issued $40.0 million in aggregate principal amount of 6.250% interest-bearing unsecured notes due October 30, 2033. |
| 2020-02-05 | The Company issued $50.0 million in aggregate principal amount of 4.280% interest-bearing unsecured notes due February 5, 2025. |
| 2020-06-03 | The Company issued $70.0 million in aggregate principal amount of 4.310% interest-bearing unsecured notes due June 3, 2025. |
| 2020-11-04 | The Company issued $50.0 million in aggregate principal amount of 4.500% interest-bearing unsecured notes due March 4, 2026. |
| 2021-03-04 | The Company issued $50.0 million in aggregate principal amount of 4.550% interest-bearing unsecured notes due March 4, 2026. |
| 2021-09-16 | The Company issued $325.0 million in aggregate principal amount of 2.625% interest-bearing unsecured notes due September 16, 2026. |
| 2022-01-20 | The Company issued $350.0 million in aggregate principal amount of 3.375% interest-bearing unsecured notes due January 20, 2027. |
| 2022-06-22 | The Company completed a term debt securitization in connection with which an affiliate of the Company issued $150.0 million in aggregate principal amount of 4.950% interest-bearing asset-backed notes due on July 20, 2031. |
| 2024-07-16 | The Company fully repaid the aggregate outstanding $105.0 million principal and $2.5 million of accrued interest pursuant to the terms of the July 2024 Notes. |
| 2024-11-26 | The Company entered into a fifth amendment to its revolving credit agreement with Sumitomo Mitsui Banking Corporation. |
| 2025-02-05 | The Company entered into the Third Amendment to the SMBC Letter of Credit Facility Agreement. |
| 2025-02-05 | The Company fully repaid the aggregate outstanding $50.0 million principal and $1.1 million of accrued interest pursuant to the terms of the February 2025 Notes. |
| 2025-03-10 | The Company issued $287.5 million in aggregate principal amount of 4.750% interest-bearing convertible unsecured notes due on September 1, 2028. |
| 2025-04-23 | The Board declared a cash distribution of $0.40 per share and a supplemental cash distribution of $0.07 per share to be paid on May 20, 2025. |
| 2025-04-29 | The Company sold 2.2 million shares of common stock for $41.5 million of net proceeds through its ATM program. |
Keywords
investment portfolio, net investment income, debt investments, equity investments, financial results, Hercules Capital
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.